智通财经APP讯,君实生物(688180.SH)发布2024年年度报告,公司2024年度营业收入19.48亿元,同比增长29.67%;归属于上市公司股东的净亏损12.81亿元,亏损收窄;归属于上市公司股东的扣除非经常性损益的净亏损12.90亿元,亏损收窄;基本每股亏损1.30元/股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.